United American Healthcare Corporation
United American Healthcare Corporation (UAHC) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
uahc · pe ratio · data through Dec 31, 2024
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for United American Healthcare Corporation (UAHC) measures how much investors pay for each dollar of the company's trailing earnings. UAHC's current PE ratio of 8.36x is calculated by dividing its stock price of $0.02 by its TTM earnings per share of $0.00. +18.6% elevated vs 5Y avg 7.0x
Source: FMP · /ratios-ttm · /analyst-estimates · 2024-12-31
PE Ratio History
2000 – 2024 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 9 fiscal years · Front-end computedMinQ1 · 25%3.4x
MedianQ3 · 75%20.7x
Max
At 8.36x, UAHC's current P/E is higher than in 78% of its annual fiscal year readings over the past 9 years — historically elevated.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Devices · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
United American Healthcare CorporationYou UAHC | $1M | 8.36x | +556.2% | $0.00 |
 Cann American Corp. CNNA | $1M | 0.19x | -84.7% | $0.01 |
 CYduct Diagnostics, Inc. CYDX | $2M | N/A | — | -$0.08 |
 Ethema Health Corporation GRST | $1M | N/A | — | -$0.00 |
 Medigene AG MDGEF | $38M | N/A | — | -$1.32 |
 ModivCare Inc. MODVQ | $0M | N/A | — | -$14.14 |
 Neon Bloom, Inc. NBCO | $1M | 2.35x | +84.7% | $0.00 |
Industry Average 2 peers with valid PE | — | 1.27x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2024-12-31Latest FY2024 | 7.38x | $0.00 | +127.8% | |
2023-12-31 FY2023 | 3.24x | $0.01 | — | |
2022-12-31 FY2022 | — | $-0.00 | — | |
2021-12-31 FY2021 | — | $-0.00 | — | |
2020-12-31 FY2020 | — | $-0.02 | — | |
2019-12-31 FY2019 | — | $-0.20 | — | |
2013-06-30 FY2013 | 0.88x | $0.05 | — | |
2012-06-30 FY2012 | — | $-0.16 | — | |
2011-06-30 FY2011 | — | $-0.73 | — | |
2010-06-30 FY2010 | — | $-0.66 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for United American Healthcare Corporation (UAHC) measures how much investors pay for each dollar of the company's trailing earnings. UAHC's current PE ratio of 8.36x is calculated by dividing its stock price of $0.02 by its TTM earnings per share of $0.00.
Frequently asked questions
UAHC pe ratio · 6 questionsUAHC's current PE ratio is 8.36x as of 2026-06-15, based on a stock price of $0.02 and TTM EPS of $0.00. Data sourced from Financial Modeling Prep via UAHC's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · United American Healthcare Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-15